{"id":492445,"date":"2026-01-04T19:37:18","date_gmt":"2026-01-04T19:37:18","guid":{"rendered":"https:\/\/www.europesays.com\/us\/492445\/"},"modified":"2026-01-04T19:37:18","modified_gmt":"2026-01-04T19:37:18","slug":"nhs-important-warning-to-people-using-mounjaro-injections-for-weight-loss","status":"publish","type":"post","link":"https:\/\/www.europesays.com\/us\/492445\/","title":{"rendered":"NHS ‘important’ warning to people using Mounjaro injections for weight loss"},"content":{"rendered":"

Patients are urged to check the latest guidance and speak to their GP if they have any questions<\/p>\n

12:44, 04 Jan 2026Updated 12:45, 04 Jan 2026<\/p>\n

\"Close Advice can be found on the NHS website (stock image)(Image: Getty)<\/p>\n

With the arrival of January, many people will be planning on starting the New Year<\/a> with new health and fitness goals, including trying to lose weight. Exercising regularly, going to the gym, and maintaining a balanced, healthy diet are key factors that help improve overall well-being and can contribute to weight loss<\/a>. However, for some people, taking these steps may not be enough.<\/p>\n

Some medications<\/a> that can help trigger weight loss can be an option for certain people, though they are typically intended for people with type 2 diabetes and potentially those who have had difficulty losing weight through lifestyle changes alone. They aren’t only for people who “can’t” lose weight<\/a> on their own, but are more like a helpful tool when other ways haven’t worked well enough.<\/p>\n

GLP-1 agonists are medications such as tirzepatide and semaglutide, often known by brand names like Mounjaro, Ozempic, or Wegovy. They are prescribed for people with type 2 diabetes or to help with chronic weight management in certain adults. These medicines work by slowing down the rate at which food leaves the stomach, by mimicking gut hormones to control blood sugar and reduce appetite.<\/p>\n

For people who are eligible for such injections and have been prescribed them by a GP, there is an important NHS<\/a> alert that patients should be aware of. It primarily affects anyone who is also taking other medications at the same time, including the contraceptive pill and Hormone Replacement Therapy (HRT).<\/p>\n

An ‘important notice’ statement can be seen on the NHS website<\/a> that’s aimed at patients using jabs and taking the pill or HRT. The health service warns that taking certain injections can reduce the effectiveness of the pill and HRT.<\/p>\n

\"TirzepatideGLP-1 agonists are medications such as tirzepatide and semaglutide (stock image)<\/p>\n

It says: “Many patients are now using weight loss medications like Tirzepatide (Mounjaro) or Semaglutide (Ozempic, Wegovy, Rybelsus) \u2014 either for diabetes or privately for weight loss. These medications work partly by slowing down how your stomach empties, which can affect how well other medicines (like the contraceptive pill or HRT tablets) are absorbed by your body.”<\/p>\n

If you take the contraceptive pill:<\/strong><\/p>\n

Tirzepatide (Mounjaro) may reduce how well any oral contraceptive works, including the Progesterone-Only Pill. The NHS says you should:<\/p>\n